Commercialisation and impact in Life Sciences
We are committed to ensuring that our research has a real and significant impact on the quality of people’s lives – their health, the economy and the environment.
Octopus Ventures 2021
The School's global reputation for research excellence has enabled us to forge important strategic partnerships and attract inward investment from industrial collaborators as well as create new high-growth life sciences spin-out companies.
This has had significant local impacts, stimulating the emergence of a regional life sciences cluster which makes a major contribution to the Tay Cities regional economy.
Our activity is supported by the specialist team in Research and Innovation Services.
Translation and collaboration with industry and external organisations
Nurturing new talent and business ideas
We offer our decades of expertise to external clients and also offer access to our world-class facilities.
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
University of Dundee spinout company Tay Therapeutics has announced a licensing deal potentially worth over $50 million in upfront and milestone payments, plus royalties.
World-leading and collaborative research undertaken at the University of Dundee has been honoured at one of the Life Sciences sector’s most prestigious award ceremonies.